Company – Market – Products

We make lung-function visible without x-rays

Mission / Objective

15.04.2023 2

Swisstom AG is dedicated to

5-15% of mechanically ventilated patients in Intensive

Care Units (ICUs) develop ARDS causing 75’000 deaths and 3.6 million hospital days in the USA alone (Rubenfeld et al. NEJM 2005, Walkey et.

al. Clin Epidemiol 2012,).

relieve patients

from the risk of severe lung injuries

caused by mechanical ventilation

during intensive care treatments or general anesthesia.

Company profile (July 2015)

Med-Tech company based in Switzerland, privately held

Market Focus: Acute Lung Injury patients in Intensive Care Medicine

Proprietary Technology: Electrical Impedance Tomography (EIT)

Business Model: EIT modules (OEM) for integration by Value Added Reseller (VAR)

QMS: EN ISO 13485-2012 certified, CE Mark received

Management: J.X.Brunner (CEO), S.H.Böhm (CMO), G.Schelling (COO)

15.04.2023 3

Market USA alone

15.04.2023 4

40% of them die (more than 40’000)Walkey et.al., Clin Epidemiol 2014, Rubenfeld et al. NEJM 2005

5 million patients are admitted annually to ICUs http://www.sccm.org/Communications/Pages/CriticalCareStats.aspx

39.4% of them are on mechanical ventilators (1.975 million)Wunsch et al Crit Care Med 2013

5%-15% of them develop ARDS (more than 100’000)Walkey et.al., Clin Epidemiol 2014, Rubenfeld et al. NEJM 2005

ARDS can be treated and outcome improved!

Correct Diagnosis

Adequate treatment

Continous monitoring with Swisstom Technology

Improved outcome

15.04.2023 5

Products with CE mark

15.04.2023 6

Swisstom BB2Salvia Elisa 800VIT OEM components

Distribution partners

15.04.2023 7

Swisstom BB2Salvia Elisa 800VIT OEM components

15.04.2023 8Launch ESICM Paris, 5-8 October 2013